MARKET

SHPHY

SHPHY

Sihuan Pharma
OTCPK

Real-time Quotes | Nasdaq Last Sale

--
0.00
0.00%
Opening 09:30 05/17 EDT
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
BRIEF-Sihuan Pharma Refers To Media Articles Purporting That Group Is Under Negotiation With Potential Investors
reuters.com · 5d ago
BUZZ-Sihuan Pharmaceutical jumps most in nearly 3 months on report of privatisation talks
reuters.com · 5d ago
BRIEF-Sihuan Pharma Says Unit To Dispose Of Entire Issued Share Capital Of Beijing Xuansheng Pharmaceutical
reuters.com · 04/18 14:29
BRIEF-Sihuan Pharma Obtained Class III Medical Device Registration Certificate From Nmpa For Exclusively Distributed Hyaluronic Acid Persnicatm
reuters.com · 04/18 14:18
BRIEF-Sihuan Pharma Says Unit To Invest In Shenzhen Yimei By Way Of Equity Transfer And Capital Increase
reuters.com · 03/14 07:12
BRIEF-Sihuan Pharma Says Unit Reached An Exclusive Distribution Agreement In Relation To Cellbooster Series Products With Suisselle SA
reuters.com · 03/07 01:33
BRIEF-Sihuan Pharma Says Got Medical Device Registration Certificate For 4 Medical Skin Care Dressing Patch Products
reuters.com · 03/02 00:41
BRIEF-Sihuan Pharma Obtains Medical Device Registration Certificate From China's NMPA For 3 Products
reuters.com · 03/01 01:29
More
No Data
Learn about the latest financial forecast of SHPHY. Analyze the recent business situations of Sihuan Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.79%
Pharmaceuticals & Medical Research
+1.16%
Key Executives
Chairman/Director
Fengsheng Che
Chief Executive Officer/Vice Chairman/Director
Weicheng Guo
Chief Financial Officer/Executive Director/Secretary
Yiau Chong Choi
Chief Operating Officer
Zhongxin Jia
Chief Investment Officer/Executive Director
Jionglong Zhang
Chief Marketing Officer/General Manager
Bo Xu
Vice President
Tingjun Yuan
Deputy General Manager
Xianhui Meng
Executive Director
Yan Ling Chen
Other
Caixia Huo
Non-Executive Director
Jin Ha Kim
Non-Executive Independent Director
Patrick Sun
Non-Executive Independent Director
Wah Kwong Tsang
Non-Executive Independent Director
Xun Zhu
No Data
No Data
About SHPHY
Sihuan Pharmaceutical Holding Group Ltd. is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company is mainly engaged in the research and development, manufacture and sales of pharmaceutical products in China. Its products are applicable in cardio-cerebral vascular (CCV) system, central nervous system, metabolism, oncology and anti-infective fields. Its CCV products include Kelinao, Anjieli and Oudimei, among others. Its non-CCV products include Ren’Ao, Metronidazole and Clindamycin, among others.

Webull offers kinds of Sihuan Pharmaceutical Holdings Group Ltd stock information, including OTCPK:SHPHY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SHPHY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SHPHY stock methods without spending real money on the virtual paper trading platform.